{"id":"W2146959803","doi":"10.1016/j.jmoldx.2013.04.007","title":"BCR-ABL1 RT-qPCR for Monitoring the Molecular Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia","year":2013,"lang":"en","type":"review","venue":"Journal of Molecular Diagnostics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"Novartis Pharmaceuticals Corporation; Ariad Pharmaceuticals; Bristol-Myers Squibb","keywords":"Dasatinib; Nilotinib; Bosutinib; Myeloid leukemia; Tyrosine kinase; Imatinib; Tyrosine-kinase inhibitor; Cancer research; Imatinib mesylate; Ponatinib; Bruton's tyrosine kinase; ABL; Medicine; Fusion gene; Biology; Internal medicine; Genetics; Cancer; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00165334,0.001026046,0.002973581,0.001011138,0.0001121682,0.00012965,0.0008253372,0.0006995768,0.00003116377],"category_scores_gemma":[0.008043668,0.00071622,0.001520151,0.001014481,0.0001213559,0.0001205418,0.0002818099,0.001731536,0.00009061545],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01507698,"about_ca_system_score_gemma":0.008496372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004981158,"about_ca_topic_score_gemma":0.000004723302,"domain_scores_codex":[0.994231,0.0006255485,0.002362978,0.0006254572,0.001176933,0.0009781001],"domain_scores_gemma":[0.9931924,0.002810584,0.001479868,0.00121376,0.0006370655,0.0006663032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007726218,0.0004396417,0.00009333088,0.01077915,0.001734037,0.0115248,0.0002149683,0.001224224,0.007167623,0.00006527236,0.007518328,0.958466],"study_design_scores_gemma":[0.005267415,0.002630459,0.0001103097,0.05770734,0.004637973,0.00139397,0.00005165434,0.00003606265,0.008815175,0.00005552631,0.9185387,0.000755458],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01610878,0.9766638,0.0009509498,0.0006002432,0.001207988,0.004356784,0.00005324696,0.00002536835,0.00003282702],"genre_scores_gemma":[0.002056235,0.9905547,0.004582544,0.000245982,0.001453284,0.0005579123,0.00004230189,0.0003226871,0.0001843441],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9577106,"threshold_uncertainty_score":0.9995289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02966965881962388,"score_gpt":0.3327350379289139,"score_spread":0.30306537910929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}